Background Papillary thyroid carcinoma (PTC) is the most common thyroid cancer. While
many patients survive, a portion of PTC cases display high aggressiveness and even …

Increasing evidence has indicated a close association between immune infiltration in cancer
and clinical outcomes. However, related research in thyroid cancer is still deficient. Our …

Background Although well-differentiated papillary thyroid cancer may remain indolent,
lymph node metastases and the recurrence rates are approximately 50% and 20 …

Head and neck cancer is the sixth most common malignancy around the world, and 90% of
cases are squamous cell carcinomas. In this study, we performed a systematic investigation …

Thyroid cancer is an excellent model for studying tumor immune microenvironment, as it
often shows local signs of an immune response. The tumor immune microenvironment of …

The incidence of papillary thyroid carcinoma (PTC) is increasing rapidly throughout the
world. Hence, there is an urgent need for identifying more specific and sensitive biomarkers …

The tumor microenvironment heterogeneity of papillary thyroid cancer (PTC) is poorly
characterized. The relationship between PTC and Hashimoto thyroiditis (HT) is also in …

Papillary thyroid carcinoma (PTC) is heterogeneous and its molecular characteristics remain
elusive. We integrated transcriptomic sequencing, genomic analysis and clinicopathologic …

Thyroid cancer is the most prevalent endocrine malignancy that comprises mostly indolent
differentiated cancers (DTCs) and less frequently aggressive poorly differentiated (PDTC) or …

The present study aimed to systematically examine the molecular mechanisms of papillary
thyroid cancer (PTC), and identify potential biomarkers and drugs for the treatment of PTC …